Mirum Pharmaceuticals, Inc. (MIRM)

Mirum Pharmaceuticals Stock Forecast

Stock Price Forecast

According to 11 professional analysts, the 12-month price target for Mirum Pharmaceuticals stock ranges from a low of $39 to a high of $77. The average analyst price target of $62.27 forecasts a 40.25% increase in the stock price over the next year.

Price Target: $62.27 (+40.25%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$39	$62.27	$66	$77
Change	-12.16%	+40.25%	+48.65%	+73.42%

Analyst Ratings

The average analyst rating for Mirum Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Dec '24	Jan '25	Feb '25	Mar '25	Apr '25	May '25
Strong Buy	5	5	4	4	4	4
Buy	8	8	7	7	7	7
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	13	13	11	11	11	11

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Steven Seedhouse Raymond James	Raymond James	Strong Buy Maintains $73 → $77	Strong Buy	Maintains	$73 → $77	+73.42%	May 13, 2025
Jonathan Wolleben JMP Securities	JMP Securities	Buy Maintains $74 → $76	Buy	Maintains	$74 → $76	+71.17%	May 9, 2025
Ed Arce HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $66 → $72	Strong Buy	Maintains	$66 → $72	+62.16%	Feb 28, 2025
Brian Skorney Baird	Baird	Buy Maintains $50 → $55	Buy	Maintains	$50 → $55	+23.87%	Feb 27, 2025
Jonathan Wolleben Citizens Capital Markets	Citizens Capital Markets	Buy Reiterates $74	Buy	Reiterates	$74	+66.67%	Feb 24, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

443.24M

Increased by 31.57%

from 336.89M

Revenue Next Year

525.97M

Increased by 18.66%

from 443.24M

EPS This Year

-0.96

from -1.85

EPS Next Year

-0.34

from -0.96

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	-	19.14M	77.06M	186.37M	336.89M	443.24M	525.97M	593.30M
Revenue Growth	-	-	302.67%	141.85%	80.76%	31.57%	18.66%	12.80%
EPS	-4.09	-2.77	-4.02	-4.00	-1.85	-0.96	-0.34	0.78
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	57.20
No. Analysts	-	-	-	-	-	12	11	8

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	477.0M	597.0M	782.8M
Avg	443.2M	526.0M	593.3M
Low	403.0M	440.7M	244.0M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	41.6%	34.7%	48.8%
Avg	31.6%	18.7%	12.8%
Low	19.6%	-0.6%	-53.6%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	-0.01	0.32	1.46
Avg	-0.96	-0.34	0.78
Low	-1.47	-1.59	-0.23

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.